Shannon Reaney

Shannon Reaney


Palo Alto, (650) 813-5744


Occidental College (B.A., 1997)
University of California, Santa Cruz (Ph.D., 2002)
Santa Clara University School of Law (J.D., 2008)

Bar Admissions

U.S. Patent & Trademark Office

Shannon Reaney counsels pharmaceutical and biotechnology clients and specializes in patent matters in the areas of organic chemistry and small molecule pharmaceuticals. With over 10 years of experience in the patent field, Dr. Reaney has a keen understanding of how to build and strengthen a patent portfolio and how to assess and manage third party intellectual property. She develops and manages large patent portfolios for mid-size to large companies and provides strategic advice on lifecycle management and issues relating to regulatory considerations. She also assists smaller clients with securing foundation intellectual property and with strategic positioning for investment or partnering opportunities.

Dr. Reaney facilitates business transactions and in-licensing opportunities through investor side and defensive due diligence. She assists venture capital firms in assessing target IP and provides opinions on patentability, validity, freedom to operate and infringement positions. Dr. Reaney assisted with a more than $225 million investment by Pfizer in firm client, Medivation, Inc., and was a key team member to other transactions such as NEA’s investment in Cardioxyl Pharmaceuticals, and Astellas Pharma, Inc.’s acquisition of OSI Pharmaceuticals.

She has worked with Medivation, Inc. since 2003 on patent portfolio management and advises biopharmaceutical companies such as Genentech in areas relating to chemistry. Other representative engagements include Gilead Sciences, Inc., Acorda Therapeutics, Inc. and Topica Pharmaceuticals, Inc.

Dr. Reaney received her J.D. from Santa Clara University and her Ph.D. in chemistry from the University of California, Santa Cruz, where her doctoral research concentrated on synthetic organic methodology and the use of lithium aminoborohydrides in novel hydride and amine transfer reactions. Prior to and throughout law school, Shannon was a patent agent at Morrison & Foerster LLP. Shannon has published several first-author papers in peer-reviewed journals and has presented her research at numerous conferences, including those sponsored by the American Chemical Society and the IUPAC World Chemistry Congress. She received a B.A. degree in biochemistry from Occidental College, where she conducted undergraduate research investigating psoralen-DNA intercalation.

Dr. Reaney is admitted to practice in California and in front of the U.S. Patent & Trademark Office.

Email Disclaimer

Unsolicited e-mails and information sent to Morrison & Foerster will not be considered confidential, may be disclosed to others pursuant to our Privacy Policy, may not receive a response, and do not create an attorney-client relationship with Morrison & Foerster. If you are not already a client of Morrison & Foerster, do not include any confidential information in this message. Also, please note that our attorneys do not seek to practice law in any jurisdiction in which they are not properly authorized to do so.

©1996-2017 Morrison & Foerster LLP. All rights reserved.